TUESDAY, Sept. 3, 2024 -- The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects...

FRIDAY, Aug.30, 2024 -- New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more...

Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and...

Semaglutide – contained in Ozempic and Wegovy – has ‘far-reaching benefits’, with people dying at lower rate from all causes

LEHI, Utah., Sept. 12, 2024. Biolexis Therapeutics, a biopharmaceutical company pioneering next-generation weight loss treatments, today announced the...

MONDAY, Sept. 9, 2024 -- A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the...

Pharmaceuticals such as Ozempic, Wegovy and Mounjaro aren't risk-free. The FDA says it has received reports of people overdosing on compounded...

Pharmaceuticals such as Ozempic, Wegovy and Mounjaro aren't risk-free. The FDA says it has received reports of people overdosing on compounded...

learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes

learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes